Literature DB >> 10625243

Localised prostate cancer: can we do better? There have been some advances in local control, but little impact on survival.

T Prior, J Waxman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10625243      PMCID： PMC1117385          DOI： 10.1136/bmj.320.7227.69

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  16 in total

1.  A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma.

Authors:  T M Pisansky; M J Kahn; G M Rasp; S S Cha; M G Haddock; D G Bostwick
Journal:  Cancer       Date:  1997-01-15       Impact factor: 6.860

2.  Results of radical prostatectomy in men with clinically localized prostate cancer.

Authors:  G S Gerber; R A Thisted; P T Scardino; H G Frohmuller; F H Schroeder; D F Paulson; A W Middleton; D B Rukstalis; J A Smith; P F Schellhammer; M Ohori; G W Chodak
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

3.  The role of androgen deprivation in the definitive management of clinically localized prostate cancer treated with radiation therapy.

Authors:  F A Vicini; V R Kini; W Spencer; A Diokno; A A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

4.  Trends in radical prostatectomy in New York State.

Authors:  P J Imperato; R P Nenner; T O Will
Journal:  Am J Med Qual       Date:  1996       Impact factor: 1.852

5.  A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy.

Authors:  M Jønler; F A Madsen; P R Rhodes; M Sall; E M Messing; R C Bruskewitz
Journal:  Urology       Date:  1996-09       Impact factor: 2.649

6.  Results of conservative management of clinically localized prostate cancer.

Authors:  G W Chodak; R A Thisted; G S Gerber; J E Johansson; J Adolfsson; G W Jones; G D Chisholm; B Moskovitz; P M Livne; J Warner
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

7.  Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.

Authors:  M V Pilepich; J M Krall; M al-Sarraf; M J John; R L Doggett; W T Sause; C A Lawton; R A Abrams; M Rotman; P Rubin
Journal:  Urology       Date:  1995-04       Impact factor: 2.649

Review 8.  Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out.

Authors:  A V D'Amico; C N Coleman
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.

Authors:  D P Dearnaley; V S Khoo; A R Norman; L Meyer; A Nahum; D Tait; J Yarnold; A Horwich
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

10.  Changes in prostate cancer incidence and treatment in USA.

Authors:  G L Lu-Yao; E R Greenberg
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321
View more
  6 in total

Review 1.  Prostate cancer.

Authors:  D Mazhar; J Waxman
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

2.  Person centred care and shared decision making: implications for ethics, public health and research.

Authors:  Christian Munthe; Lars Sandman; Daniela Cutas
Journal:  Health Care Anal       Date:  2012-09

3.  Men with prostate cancer over the first year of illness: their experiences as biographical disruption.

Authors:  Sandi Cayless; Liz Forbat; Nicola Illingworth; Gill Hubbard; Nora Kearney
Journal:  Support Care Cancer       Date:  2009-04-07       Impact factor: 3.603

4.  Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer.

Authors:  Gill Haddow; Emma King; Ian Kunkler; Duncan McLaren
Journal:  Sci Cult (Lond)       Date:  2015-09-03

5.  Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.

Authors:  Mohammed T Tayeb; Caroline Clark; Graeme I Murray; Linda Sharp; Neva E Haites; Howard L McLeod
Journal:  Ann Saudi Med       Date:  2004 Jan-Feb       Impact factor: 1.526

6.  CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.

Authors:  M T Tayeb; C Clark; N E Haites; L Sharp; G I Murray; H L McLeod
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.